In silico studies of natural product-like caffeine derivatives as potential MAO-B inhibitors/AA_2AR antagonists for the treatment of Parkinson’s disease

September 19, 2022

Recommended citation: Y. Boulaamane, M. A. Ibrahim, M. R. Britel, A. Maurady, Journal of Integrative Bioinformatics 2022, DOI 10.1515/jib-2021-0027. /files/paper-2.pdf